TNO starts large research program in Food Allergy

08 Apr 2016

Approximately 2 to 4% of the people suffer from having a food allergy. At the moment, the treatment of food allergy mainly consists of  the avoidance of food products containing substances to which the consumer is allergic. This is a large burden for allergic consumers and their environment, since avoiding such substances is not always possible. Due to this, the substance in question may still be consumed causing an unexpected allergic reaction, which can even be fatal. Current medication is aimed at the treatment of this unexpected allergic reaction. Therefore, having a food allergy will have a major impact on quality of life.

Public-private cooperation

As of January 1, 2016, TNO has launched a Shared Research Program in the field of food allergy. To reduce the impact of food allergy and possibly even prevent or cure food allergy, there are four major goals:

  • To improve the protection of the food allergic consumer
  • To prevent the introduction of new strong allergenic proteins or products in our food
  • To develop strategies for the treatment of food allergy
  • To develop strategies for the prevention of the development of food allergy

In the Shared Research Program, in which public and private parties cooperate, a collaboration with, among others, Mars, Dupont, Syngenta and the University of Nebraska (Food Allergy Research and Resource Program) is established. The program is expected to have a duration of at least 6 to 8 years and the initiative is open to other partners to join.

In case you want more information about the program, please contact Dr. Geert Houben, Program Leader of the TNO Shared Research Program Food Allergy.


Food safety

Food-safety testing is often time-consuming and uncertain. TNO develops advanced methods that provide fast, accurate information on allergenicity and on the microbiological and toxicological safety of... Read more

Risk Analysis for Products In Development (RAPID)

RAPID investigates the quality and safety of chemical substances, food ingredients/products, drugs and nanoparticles. Traditionally, research at RAPID has taken place within (inter)national legislative... Read more

Healthy living: ‘Focussing on participation, not on the disease’

We are all living longer in the Netherlands. We need more care as a result. Prevention, high-quality care and cost control are the most important issues we will face in the coming years. ‘It is a challenging... Read more

We use anonymous cookies to enhance the use of our site.